These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38892433)

  • 1. Evaluation of Whole Genome Sequencing-Based Predictions of Antimicrobial Resistance to TB First Line Agents: A Lesson from 5 Years of Data.
    Sharma MK; Stobart M; Akochy PM; Adam H; Janella D; Rabb M; Alawa M; Sekirov I; Tyrrell GJ; Soualhine H
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
    Feliciano CS; Namburete EI; Rodrigues Plaça J; Peronni K; Dippenaar A; Warren RM; Silva WA; Bollela VR
    Tuberculosis (Edinb); 2018 May; 110():59-67. PubMed ID: 29779775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.
    ; Allix-Béguec C; Arandjelovic I; Bi L; Beckert P; Bonnet M; Bradley P; Cabibbe AM; Cancino-Muñoz I; Caulfield MJ; Chaiprasert A; Cirillo DM; Clifton DA; Comas I; Crook DW; De Filippo MR; de Neeling H; Diel R; Drobniewski FA; Faksri K; Farhat MR; Fleming J; Fowler P; Fowler TA; Gao Q; Gardy J; Gascoyne-Binzi D; Gibertoni-Cruz AL; Gil-Brusola A; Golubchik T; Gonzalo X; Grandjean L; He G; Guthrie JL; Hoosdally S; Hunt M; Iqbal Z; Ismail N; Johnston J; Khanzada FM; Khor CC; Kohl TA; Kong C; Lipworth S; Liu Q; Maphalala G; Martinez E; Mathys V; Merker M; Miotto P; Mistry N; Moore DAJ; Murray M; Niemann S; Omar SV; Ong RT; Peto TEA; Posey JE; Prammananan T; Pym A; Rodrigues C; Rodrigues M; Rodwell T; Rossolini GM; Sánchez Padilla E; Schito M; Shen X; Shendure J; Sintchenko V; Sloutsky A; Smith EG; Snyder M; Soetaert K; Starks AM; Supply P; Suriyapol P; Tahseen S; Tang P; Teo YY; Thuong TNT; Thwaites G; Tortoli E; van Soolingen D; Walker AS; Walker TM; Wilcox M; Wilson DJ; Wyllie D; Yang Y; Zhang H; Zhao Y; Zhu B
    N Engl J Med; 2018 Oct; 379(15):1403-1415. PubMed ID: 30280646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of WHO catalog of mutations and five WGS analysis tools for drug resistance prediction of
    He G; Zheng Q; Shi J; Wu L; Huang B; Yang Y
    Microbiol Spectr; 2024 Aug; 12(8):e0334123. PubMed ID: 38904370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand.
    Prommi A; Wongjarit K; Petsong S; Somsukpiroh U; Faksri K; Kawkitinarong K; Payungporn S; Rotcheewaphan S
    Microbiol Spectr; 2024 Mar; 12(3):e0346223. PubMed ID: 38323824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China.
    Wu X; Gao R; Shen X; Guo Y; Yang J; Wu Z; Tan G; Wang H; Yu F
    Int J Infect Dis; 2020 Jul; 96():48-53. PubMed ID: 32339720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Whole-Genome Sequencing to Predict
    Wu X; Tan G; Sha W; Liu H; Yang J; Guo Y; Shen X; Wu Z; Shen H; Yu F
    Microbiol Spectr; 2022 Apr; 10(2):e0251621. PubMed ID: 35311541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying whole genome sequencing to predict phenotypic drug resistance in
    Kurtzhals ML; Norman A; Svensson E; Lillebaek T; Folkvardsen DB
    Antimicrob Agents Chemother; 2024 Aug; 68(8):e0043024. PubMed ID: 38904390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence Setting.
    Andres S; Gröschel MI; Hillemann D; Merker M; Niemann S; Kranzer K
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
    Mesfin EA; Merker M; Beyene D; Tesfaye A; Shuaib YA; Addise D; Tessema B; Niemann S
    PLoS One; 2022; 17(8):e0271508. PubMed ID: 35930613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance.
    Park M; Lalvani A; Satta G; Kon OM
    BMC Infect Dis; 2022 Apr; 22(1):349. PubMed ID: 35392842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
    Vīksna A; Sadovska D; Berge I; Bogdanova I; Vaivode A; Freimane L; Norvaiša I; Ozere I; Ranka R
    BMC Infect Dis; 2023 Sep; 23(1):638. PubMed ID: 37770850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Five User-Friendly Whole Genome Sequencing Software for
    Kim N; Seok KH; Shin S; Kim B; Park H; Roh EY; Yoon JH; Shin S
    J Korean Med Sci; 2022 Nov; 37(46):e328. PubMed ID: 36631026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Rapid Drug Resistance Genotyping Workflow for Mycobacterium tuberculosis, Using Targeted Isothermal Amplification and Nanopore Sequencing.
    Gliddon HD; Frampton D; Munsamy V; Heaney J; Pataillot-Meakin T; Nastouli E; Pym AS; Steyn AJC; Pillay D; McKendry RA
    Microbiol Spectr; 2021 Dec; 9(3):e0061021. PubMed ID: 34817282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping.
    Quan TP; Bawa Z; Foster D; Walker T; Del Ojo Elias C; Rathod P; ; Iqbal Z; Bradley P; Mowbray J; Walker AS; Crook DW; Wyllie DH; Peto TEA; Smith EG
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29167290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis.
    Eltringham IJ; Wilson SM; Drobniewski FA
    J Clin Microbiol; 1999 Nov; 37(11):3528-32. PubMed ID: 10523547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming the pitfalls of automatic interpretation of whole genome sequencing data by online tools for the prediction of pyrazinamide resistance in Mycobacterium tuberculosis.
    Iwamoto T; Murase Y; Yoshida S; Aono A; Kuroda M; Sekizuka T; Yamashita A; Kato K; Takii T; Arikawa K; Kato S; Mitarai S
    PLoS One; 2019; 14(2):e0212798. PubMed ID: 30817803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs.
    Jouet A; Gaudin C; Badalato N; Allix-Béguec C; Duthoy S; Ferré A; Diels M; Laurent Y; Contreras S; Feuerriegel S; Niemann S; André E; Kaswa MK; Tagliani E; Cabibbe A; Mathys V; Cirillo D; de Jong BC; Rigouts L; Supply P
    Eur Respir J; 2021 Mar; 57(3):. PubMed ID: 32943401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
    Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
    Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.